Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efinaconazole in pediatric onychomycosis
NCT02812771Phase 4Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Aug 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of efinaconazole in onychomycosis, sponsored by Valeant Pharmaceuticals. Started Aug 2016; status: completed.
02
Drugs
efinaconazole
03
Conditions
onychomycosis
Beyond the preview
Go deeper on NCT02812771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02812771.